MediWound (NASDAQ:MDWD) Receives “Buy” Rating from HC Wainwright
MediWound (NASDAQ:MDWD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $25.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 53.66% from the stock’s […]
MediWound (NASDAQ:MDWD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $25.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 53.66% from the stock’s […]
